New BA.3.2 Covid Variant Spreading Across US, May Evade Current Vaccines
A new variant of COVID-19, designated BA.3.2 and nicknamed Cicada, is spreading rapidly across the United States, raising concerns about potential vaccine evasion. This strain, which has circulated quietly since late 2024, is now accelerating its transmission, having been detected in patients and wastewater systems across 29 states.
Origins and Spread of the BA.3.2 Variant
BA.3.2 is directly descended from the Omicron variant that first emerged in late 2021. Researchers initially identified this new strain in November 2024 in Africa. It began its global journey in 2025 and had reached 23 countries by February 2026. The first confirmed case in the United States was detected in June 2025 in a traveler entering the country.
Wastewater monitoring has proven to be one of the most effective early detection methods for tracking strain shifts like this. However, the number of states submitting wastewater data to the Centers for Disease Control and Prevention has declined since around 2022, following the peak of the pandemic.
Genetic Changes and Vaccine Implications
Compared to the predominant JN.1 lineage strains that have dominated since January 2024, BA.3.2 carries between 70 and 75 genetic changes in its spike protein. This is the critical component of the virus that facilitates cellular entry and serves as the primary target for vaccine-induced immune responses.
Current COVID-19 vaccines are specifically designed to protect against JN.1 lineage strains. The substantial genetic differences in BA.3.2 mean the vaccine may not prime the immune system as effectively against this new variant, potentially allowing it to evade detection. A poorly matched vaccine simply won't recognize the new variant as quickly, which means it takes longer for the immune system to mount its defense.
This doesn't mean vaccination is ineffective - extensive evidence demonstrates that vaccines continue to reduce hospitalizations and deaths from COVID-19. However, the mismatch could delay immune recognition and response.
Severity and Public Health Implications
Despite its rapid spread, there is no indication that BA.3.2 causes more severe disease than previous variants that circulated during the winter of 2025-26. The primary concern stems from its potential to infect more people widely due to reduced immune recognition, possibly leading to a spike in COVID-19 cases.
Protection remains crucial, particularly for individuals with chronic health conditions who face higher risks of severe illness from COVID-19 infections. While the incidence of long COVID has decreased as the virus has evolved since the early pandemic, it still occurs in approximately 3% of cases.
Protective Measures and Recommendations
Medical experts recommend several commonsense steps to minimize infection risks:
- Hand Hygiene: Wash hands thoroughly after using restrooms, before preparing or consuming food, and following contact with sick individuals. Proper handwashing can reduce respiratory infection risks by 16% to 21%.
- Stay Home When Unwell: If experiencing symptoms, remain home to recover and prevent disease transmission. This consideration is particularly important for protecting vulnerable individuals with conditions like cancer or chronic lung disease.
- Outdoor Activities: Reduce time in crowded indoor environments by increasing outdoor activities to lower exposure risks.
- Consult Healthcare Providers: Individuals with specific health concerns should discuss their COVID-19 risks with trusted clinicians who can provide personalized advice based on individual circumstances.
As a pulmonary and critical care physician, I regularly treat patients at high risk for severe COVID-19 due to chronic lung conditions, as well as those living with long COVID. All express understandable concern about emerging variants. While BA.3.2 presents new challenges, particularly regarding vaccine matching, it doesn't appear to represent increased danger in terms of disease severity.
The virus continues to evolve, and our understanding and responses must adapt accordingly. Regular handwashing, staying home when symptomatic, reducing crowded indoor exposure, and consulting healthcare providers about individual risks remain fundamental protective strategies.
